Robust IPO activity in late 2026, including multiple deals priced or scheduled for October and November, reflects strong equity market conditions and investor demand for growth sectors. Recent filings and pricings, such as SPACCircle Acquisition on October 27 and upcoming offerings from Aspen Neuroscience, Bambusa Therapeutics, and OPay on October 30, demonstrate continued momentum. Anthropic’s S-1 filing on October 26, targeting a potential mid-November debut with substantial revenue growth, highlights AI-driven interest amid elevated valuations. Broader pipeline data shows 260 U.S. IPOs year-to-date through October 27, supported by favorable Treasury yields and Nasdaq performance, with additional catalysts from regulatory approvals and earnings visibility expected before year-end.